← All trials
NCT05874037
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 15, 2023
- Primary completion
- May 15, 2025
- Completion date
- May 15, 2025
- First posted
- May 24, 2023
- Last posted
- Aug 14, 2023
- Enrollment
- 300
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Washington University in St. LouisLead sponsor
- Washington University in St. LouisOverall official - principal investigator
- Washington University in St. LouisOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.